Venture money has been tight for over three years and counting, so a few ortho businesses are tapping into the IPO markets.
CarlsMed, Hinge Health and Shoulder Innovations are lined up on the IPO runway now.
However, in 2026 there will be a new Stock Exchange in which to go public. Texas is super pro-business (one of the reasons that I recently moved back to Texas).
In a move that could reshape how orthopedic innovators take their breakthroughs public, the U.S. Securities and Exchange Commission (SEC) greenlit the Texas Stock Exchange (TXSE). This Dallas-based, fully electronic national securities exchange isn't just another trading floor—it's a tailored gateway for mid- and large-cap companies, with a laser focus on Texas and Southeast powerhouses. For orthopedic firms eyeing an IPO, TXSE promises a homegrown alternative to the NYSE and Nasdaq, blending high listing standards with regional roots.
Picture this: Your next-gen ortho startup, based in the US or OUS, could debut on a platform designed for Southern grit and global reach.
TXSE's rollout kicks off in 2026 with initial trading operations, including dual listings for established players transitioning from traditional ...
